Bevacizumab in Non Small Cell Lung Cancer: Development, Current Status and Issues

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|7|961-971

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.7, 2012-03, pp. : 961-971

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab in Non-Small Cell Lung Cancer

By Francesco Di Costanzo  

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 737-746

Adis International

Access to resources Recommend Favorite

Role of Genotyping in Non-Small Cell Lung Cancer Treatment: Current Status

By Bonanno Laura   Favaretto Adolfo   Rugge Massimo   Taron Miquel   Rosell Rafael  

Drugs, Vol. 71, Iss. 17, 2011-12 ,pp. : 2231-2246

Adis International

Access to resources Recommend Favorite

Bowel perforation in non-small cell lung cancer after bevacizumab therapy

By Schellhaas Elisabeth   Loddenkemper Christoph   Schmittel Alexander   Buhr Heinz-J.   Pohlen Uwe  

Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. : 184-187

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab AVAiLs in non-small cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Neoadjuvant chemotherapy and chemoradiotherapy for non-small cell lung cancer: current status and future prospects

By Edelman Martin J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 843-852

Informa Healthcare

Access to resources Recommend Favorite